Clinica Medica San Judas Tadeo is categorized under Clinics in Inglewood, CA and active since 2001.
Clinica Medica San Judas Tadeo was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Benjamin Trujillo, Manager at the company’s single location by writing to 1000 South La Brea Avenue # 2, Inglewood, California CA 90301 or by phoning (310) 330-4818. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinica Medica San Judas Tadeo |
| Contact Person: | Benjamin Trujillo, Manager |
| Address: | 1000 South La Brea Avenue # 2, Inglewood, California 90301 |
| Phone Number: | (310) 330-4818 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Clinica Medica San Judas Tadeo was started in 2001 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Benjamin Trujillo, Manager for inquiries that concern Clinica Medica San Judas Tadeo by calling the company number (310) 330-4818, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinica Medica San Judas Tadeo can be found at the coordinates 33.95029,-118.3525 as well as the street address 1000 South La Brea Avenue # 2 in Inglewood, California 90301.
For its online presence, you may visit Clinica Medica San Judas Tadeo’s website at and engage with its social media outlets through on Twitter and on Facebook.